ALS
A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model.
A therapy using a monoclonal antibody to <span class="gene" id="20348957-4-41-46">CD40L</span> was developed that slows weight loss, delays paralysis and extends survival in an <span class="disease" id="20348957-4-129-132">ALS</span> mouse model.